BRIEF-Rosetta Genomics enters research collaboration using microrna biomarkers to predict response to leading immuno-oncology drug nivolumab in lung cancer patients
* Rosetta genomics enters research collaboration using
microrna biomarkers to predict response to leading
immuno-oncology drug nivolumab in lung cancer patients
No comments:
Post a Comment